We are live on ! Find out more
CH

CVI Holdings Portfolio holdings

AUM $116M
1-Year Est. Return 5.68%
This Fund
S&P 500
This Quarter Est. Return
+6.43%
1 Year Est. Return
+5.68%
3 Year Est. Return
+25.77%
5 Year Est. Return
+327.29%
10 Year Est. Return
AUM
$266M
AUM Growth
-$519M
Cap. Flow
-$520M
Cap. Flow %
-195.59%
Top 10 Hldgs %
24.71%
Holding
657
New
41
Increased
1
Reduced
224
Closed
243
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
POL.WS
126
DELISTED
Polished.com Inc. Warrants to Purchase Common Stock
POL.WS
$315K 0.12%
3,187,480
MRT icon
127
Marti Technologies
MRT
$159M
$274K 0.1%
26,354
-1,303
-5% -$13.5K
TRTL
128
DELISTED
TortoiseEcofin Acquisition Corp. III
TRTL
$262K 0.1%
25,656
-4,344
-14% -$44K
GOGN
129
DELISTED
GoGreen Investments Corporation
GOGN
$262K 0.1%
24,829
-81,696
-77% -$855K
TTOO
130
DELISTED
T2 Biosystems, Inc
TTOO
$253K 0.1%
+5,495
New +$600K
SONN
131
DELISTED
Sonnet BioTherapeutics
SONN
$253K 0.1%
+3,987
New +$645K
CLLS
132
Cellectis
CLLS
$277M
$250K 0.09%
+129,434
New +$324K
VKTX icon
133
Viking Therapeutics
VKTX
$3.7B
$250K 0.09%
+15,000
New +$155K
CLRC
134
DELISTED
ClimateRock Class A Ordinary Shares
CLRC
$247K 0.09%
23,786
-25,814
-52% -$266K
SURGW
135
DELISTED
SurgePays, Inc. Warrant
SURGW
$241K 0.09%
197,185
BNNR
136
DELISTED
Banner Acquisition Corp. Class A Common Stock
BNNR
$220K 0.08%
21,500
DNA.WS
137
DELISTED
Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share
DNA.WS
$220K 0.08%
1,222,593
-233,585
-16% -$53.5K
JOBY.WS icon
138
Joby Aviation Warrants
JOBY.WS
$201K 0.08%
309,132
-163,806
-35% -$105K
PBLA
139
DELISTED
Panbela Therapeutics, Inc. Common Stock
PBLA
$175K 0.07%
+658
New +$638K
NRDY.WS
140
DELISTED
Nerdy Inc. Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share
NRDY.WS
$171K 0.06%
262,406
-15,700
-6% -$6.6K
HMAC
141
DELISTED
Hainan Manaslu Acquisition Corp. Ordinary shares
HMAC
$169K 0.06%
16,300
-8,700
-35% -$89.3K
IMAQR
142
DELISTED
International Media Acquisition Corp. Rights
IMAQR
$165K 0.06%
1,200,000
AFAR
143
DELISTED
Aura FAT Projects Acquisition Corp Class A Ordinary Shares
AFAR
$159K 0.06%
15,126
-9,456
-38% -$98K
EVLO
144
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
$152K 0.06%
42,029
-31,550
-43% -$487K
PLMJ
145
DELISTED
Plum Acquisition Corp. III Class A Ordinary Shares
PLMJ
$138K 0.05%
13,500
-1,500
-10% -$15.2K
MTVC
146
DELISTED
Motive Capital Corp II
MTVC
$128K 0.05%
12,278
-48,300
-80% -$500K
GWH.WS
147
DELISTED
ESS Tech Inc Warrant
GWH.WS
$128K 0.05%
591,145
SVRN
148
OceanPal Inc
SVRN
$12.1M
$127K 0.05%
+36
New +$254K
CLNN icon
149
PUT
Clene
CLNN
$64M
$126K 0.05%
+5,560
New +$144K
AVPTW
150
DELISTED
AvePoint Inc Warrant
AVPTW
$123K 0.05%
217,954
-51,807
-19% -$35.5K

Similar funds

CVI Holdings's Q1 2023 Portfolio in Review

As of Q1 2023, CVI Holdings held 657 positions worth $266M, down 66% from $784M the previous quarter. Its ten largest holdings account for 25% of the portfolio.

CVI Holdings withdrew a net $520M in Q1 2023, closing 243 positions and reducing 224 holdings. Its most notable exit was ImmunityBio, an estimated $38.6M position sold in full.

By sector, the portfolio is most concentrated in Financials at 68% of assets, up from 64% a quarter earlier, followed by Healthcare and Technology.

Against the trend, CVI Holdings opened a new position in GeneDx Holdings worth $3.56M.

  • CVI Holdings's largest Q1 2023 buy was GeneDx Holdings: 295,706 shares worth $3.56M.
  • CVI Holdings added most to TPG Pace Beneficial II Corp. in Q1 2023, an estimated $82.2K increase.
  • CVI Holdings's biggest Q1 2023 reduction was RTB Digital, cutting an estimated $1.96M.
  • CVI Holdings fully exited ImmunityBio in Q1 2023, selling an estimated $38.6M.
  • CVI Holdings's ten largest holdings make up 25% of its $266M portfolio in Q1 2023.
  • CVI Holdings opened 41 new positions and closed 243 in Q1 2023.
  • CVI Holdings's portfolio value fell 66% quarter-over-quarter to $266M.

Based on CVI Holdings's 13F filing for Q1 2023, filed 16 May 2023.